Solutions
Make faster decisions, reduce risk, and unlock new opportunities with the only global development, research, and manufacturing partner dedicated exclusively to animal health.

200+
projects supported through to registered products
3
EMA- and FDA-approved GMP manufacturing facilities
125+
commercial products manufactured
50+
countries supplied
100+
veterinarians and clinical trial staff
Splitting your animal health product development across separate research, development, and manufacturing partners leads to more handoffs, slower decision-making, and costly late-stage surprises.
Instead, bring every stage into one ecosystem, with your teams aligned from the first study, so you can:


Turn your molecule into a product you can manufacture, with formulation, analytical, and process development across a wide range of dosage forms.
Generate the preclinical and clinical data your registration needs, from first-in-animal studies to GCP field trials.
Move your product into GMP manufacturing and supply your market at a commercial scale.
Get high-level and detailed risk assessments, including projected technical and commercial probabilities of success, to support your funding strategy.
Run pharmacokinetic, palatability, and challenge studies in our own AAALAC-accredited ABSL-2 facilities, then take your product into clinical studies across species from cats, dogs, and horses to cattle, poultry, aquaculture, and even bees.
License our controlled-release intraruminal capsule, long-acting microspheres, or soft chew technology to differentiate a new molecule or extend the life of an existing product.
Bring us hormone products, controlled drugs, and flammable liquids, all manufactured in our own GMP facilities.
Your CMC development programme follows a single plan, with one Argenta project team accountable for timelines and deliverables at every stage.Our four EMA- and FDA-approved, GMP-compliant sites can support your product at every stage—from formulation and delivery systems to packaging—ensuring quality, scalability, and efficiency.
A named alliance manager keeps your leadership and ours aligned across all your programmes and sites, chairs regular governance reviews, and handles escalations as they arise.
When you’re ready to file, our in-house regulatory affairs team can help compile the CMC, safety, efficacy, and food safety sections with your team, so you submit a single coordinated dossier.

CMC development spans six stages, and each stage pairs with a clinical or regulatory milestone in a parallel workstream. Our team can run both streams for you, or work alongside your own clinical partners if you prefer.






More than 200 veterinary drug development projects have made the journey with us to registered products. Some ran with us from proof of concept to commercialisation, while others joined partway or moved on to external manufacturing. Whichever route fits your product, you get fewer handoffs and faster decisions at every stage you run with us.

Whether you’re an established animal health company or a start-up, you can start at any stage, work with us on your terms, and choose the engagement model that fits your funding:
Not sure if your idea is ready?
Start with an opportunity assessment to decide whether, and how, to take your product idea forward.
Throughout the entire lifecycle — from concept to commercialisation — Argenta partners with you to navigate product development complexities and maximise chances of success. Our flexible model means you can engage with only the services you need, whether that’s all of them or just one.
Wherever you are in your product development journey, Argenta is here to help.
Product development is a complex and costly endeavour. But with our staged approach, we help decrease financial risk early in the product lifecycle, giving you product development peace of mind.
And, with 200+ years of collective experience, our multidisciplinary team ensures you know what to expect at every stage.